First Time Loading...
A

Ambrx Biopharma Inc
NYSE:AMAM

Watchlist Manager
Ambrx Biopharma Inc
NYSE:AMAM
Watchlist
Price: 28 USD 0.07% Market Closed
Updated: Apr 18, 2024
Section:
 

Wall Street
Price Targets

AMAM Price Targets Summary
Ambrx Biopharma Inc

Wall Street analysts forecast AMAM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMAM is 28.67 USD .

AMAM Lowest Forecast
Wall Street Target
Not Available
AMAM Average Forecast
Wall Street Target
28.67 USD
2% Upside
AMAM Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
28.67 USD
2% Upside
Highest
Price Target
Not Available
Ambrx Biopharma Inc Competitors:
Price Targets
AMRN
Amarin Corporation PLC
23% Upside
CDTX
Cidara Therapeutics Inc
624% Upside
B
BLRX
BioLine RX Ltd
83% Downside
DYAI
Dyadic International Inc
355% Upside
AMRN
Amarin Corporation PLC
23% Upside
CDTX
Cidara Therapeutics Inc
624% Upside
B
BLRX
BioLine RX Ltd
83% Downside
DYAI
Dyadic International Inc
355% Upside
NKTX
Nkarta Inc
153% Upside
B
300289
Beijing Leadman Biochemistry Co Ltd
310% Upside
NBIX
Neurocrine Biosciences Inc
17% Upside
P
PNT
POINT Biopharma Global Inc
0% Downside

Revenue
Forecast

Revenue Estimate
Ambrx Biopharma Inc

For the last 2 years the compound annual growth rate for Ambrx Biopharma Inc's revenue is -26%. The projected CAGR for the next 4 years is -13%.

-26%
Past Growth
-13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ambrx Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ambrx Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
AMAM intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMAM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMAM stock valuation using valuation multiples.
Wall Street Estimates
AMAM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMAM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMAM's stock price target?
Price Target
28.67 USD

According to Wall Street analysts, the average 1-year price target for AMAM is 28.67 USD .

What is Ambrx Biopharma Inc's Revenue forecast?
Projected CAGR
-13%

For the last 2 years the compound annual growth rate for Ambrx Biopharma Inc's revenue is -26%. The projected CAGR for the next 4 years is -13%.

ALPHA SPREAD
Join more than 129,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.